Skip to content

Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy

Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy: a Multicenter Prospective Cardiopulmonary Exercise Testing Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05754489
Enrollment
90
Registered
2023-03-03
Start date
2022-04-20
Completion date
2024-04-30
Last updated
2023-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Output Measurement, Cardiopulmonary Exercise Test, Hypertrophic Cardiomyopathy

Brief summary

Fatigue and dyspnea that reduce exercise performance are common symptoms in patients with hypertrophic cardiomyopathy. Since the cause of this functional limitation has not yet been described, this study aims to evaluate the cardiopulmonary parameters measured at cardiopulmonary exercise test in combination with those obtained by non-invasive measurement of cardiac output by impedance (Physioflow) and echocardiography. These results will help to better define the mechanisms underlying limitation in these patients, also in relation to the degree of LVOT obstruction. The aim of the present study is to assess the cardiopulmonary response to exercise in patients with hypertrophic cardiomyopathy, based on the degree of LVOT obstruction, by adding non-invasive measurement of cardiac output by Physioflow and echocardiographic parameters to the cardiopulmonary exercise test parameters associated with stroke volume and cardiac output (ie. VO2/WR, O2pulse) Consecutive patients with a previous diagnosis of hypertrophic cardiomyopathy on optimised medical therapy will be enrolled to perform a cardiopulmonary exercise test with simultaneous measurement of cardiac output and an exercise echocardiogram for clinical routine.

Interventions

None listed

Sponsors

Azienda Sanitaria Universitaria Giuliano Isontina [ASUGI], Università di Trieste, Italy
CollaboratorUNKNOWN
Azienda Ospedaliera Sant'Andrea
CollaboratorOTHER
Centro Cardiologico Monzino
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* hypertrophic cardiomyopathy diagnosis

Exclusion criteria

* use of long-term oxygen therapy; * presence of comorbidities affecting the ability to perform cardiopulmonary exercise test or interfering with exercise performance; * concomitant at least moderate chronic obstructive pulmonary disease

Design outcomes

Primary

MeasureTime frameDescription
cardiac output measurementimmediately after the evaluationEvaluate cardiopulmonary exercise test parameters associated with stroke volume and cardiac output (ie. VO2/WR, O2pulse) with the addition of non-invasive measurement of cardiac output using Physioflow.

Secondary

MeasureTime frameDescription
Correlation with echocardiographic variablesimmediately after the evaluationCorrelate functional and metabolic data with echocardiographic variables collected at rest and under stress.

Countries

Italy

Contacts

Primary ContactPiergiuseppe Agostoni, Prof.
piergiuseppe.agostoni@ccfm.it+39 0258002772

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026